Delphine Mérino

3.8k total citations · 1 hit paper
39 papers, 2.7k citations indexed

About

Delphine Mérino is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Delphine Mérino has authored 39 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 15 papers in Cancer Research and 13 papers in Immunology. Recurrent topics in Delphine Mérino's work include Cell death mechanisms and regulation (21 papers), Cancer Genomics and Diagnostics (8 papers) and NF-κB Signaling Pathways (6 papers). Delphine Mérino is often cited by papers focused on Cell death mechanisms and regulation (21 papers), Cancer Genomics and Diagnostics (8 papers) and NF-κB Signaling Pathways (6 papers). Delphine Mérino collaborates with scholars based in Australia, France and United States. Delphine Mérino's co-authors include Olivier Micheau, Éric Solary, Najoua Lalaoui, Alexandre Morizot, Andreas Strasser, Philippe Bouillet, Geoffrey J. Lindeman, Jane E. Visvader, Marie-Liesse Asselin-Labat and Andrew W. Roberts and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Delphine Mérino

38 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatial omics and multiplexed imaging to explore cancer biology

2021 341 citations Marie-Liesse Asselin-Labat, Jean Berthelet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Delphine Mérino Australia	26	1.9k	772	634	536	235	39	2.7k
Soner Altiok United States	27	2.1k 1.1×	1.3k 1.7×	758 1.2×	646 1.2×	433 1.8×	60	3.5k
Prafulla C. Gokhale United States	24	1.4k 0.7×	779 1.0×	358 0.6×	319 0.6×	318 1.4×	84	2.4k
Vita Golubovskaya United States	39	2.3k 1.2×	1.6k 2.1×	636 1.0×	705 1.3×	214 0.9×	93	4.3k
Claudia Kowolik United States	26	1.6k 0.8×	1.3k 1.7×	739 1.2×	427 0.8×	307 1.3×	43	2.9k
Stephanie Grabow Australia	19	1.6k 0.8×	590 0.8×	595 0.9×	272 0.5×	112 0.5×	33	2.2k
Marion Dorsch United States	32	2.2k 1.2×	1.2k 1.6×	889 1.4×	591 1.1×	345 1.5×	55	3.7k
Joan Montero United States	20	1.4k 0.7×	657 0.9×	284 0.4×	387 0.7×	194 0.8×	43	2.3k
Pádraig D’Arcy Sweden	26	2.3k 1.2×	951 1.2×	341 0.5×	422 0.8×	169 0.7×	61	2.8k
Kim H.T. Paraiso United States	23	1.9k 1.0×	954 1.2×	589 0.9×	368 0.7×	373 1.6×	28	2.5k
Peter M. Haverty United States	29	2.4k 1.2×	846 1.1×	298 0.5×	677 1.3×	351 1.5×	38	3.3k

Countries citing papers authored by Delphine Mérino

Since Specialization

Citations

This map shows the geographic impact of Delphine Mérino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Mérino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Mérino more than expected).

Fields of papers citing papers by Delphine Mérino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Mérino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Mérino. The network helps show where Delphine Mérino may publish in the future.

Co-authorship network of co-authors of Delphine Mérino

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Mérino. A scholar is included among the top collaborators of Delphine Mérino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Mérino. Delphine Mérino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thompson, Emma J., et al.. (2025). Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry. Molecular Oncology. 19(9). 2537–2556.

Jenkins, Laura J., Ian Y. Luk, Fiona Chionh, et al.. (2024). BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAFV600E colorectal cancer. Cell Death and Disease. 15(3). 183–183. 4 indexed citations

Serrano, Antonin, Tom Weber, Jean Berthelet, et al.. (2023). Experimental and spontaneous metastasis assays can result in divergence in clonal architecture. Communications Biology. 6(1). 821–821. 2 indexed citations

Berthelet, Jean, Momeneh Foroutan, Dharmesh D. Bhuva, et al.. (2022). Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin. Cancers. 14(10). 2404–2404. 1 indexed citations

Smith, Jai, Hyun‐Jung Cho, Christina Mølck, et al.. (2022). Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models. Cancers. 14(3). 581–581. 6 indexed citations

Mérino, Delphine, Tom Weber, Antonin Serrano, et al.. (2019). Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nature Communications. 10(1). 766–766. 107 indexed citations

Redvers, Richard P., Scott Ayton, Irmina Diala, et al.. (2019). Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Research. 21(1). 94–94. 122 indexed citations

Mérino, Delphine, Gemma L. Kelly, Guillaume Lessène, et al.. (2018). BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines. Cancer Cell. 34(6). 879–891. 231 indexed citations

Weeden, Clare E., Casey Ah-Cann, Aliaksei Z. Holik, et al.. (2018). Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition. Oncogene. 37(32). 4475–4488. 72 indexed citations

10.

Khaw, Seong Lin, Delphine Mérino, Mary Ann Anderson, et al.. (2014). Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199. Leukemia. 28(6). 1207–1215. 69 indexed citations

11.

Mérino, Delphine, Sarah A. Best, Marie-Liesse Asselin-Labat, et al.. (2014). Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2. Oncogene. 34(30). 3926–3934. 31 indexed citations

12.

Vaillant, François, Delphine Mérino, Lily Lee, et al.. (2013). Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer. Cancer Cell. 24(1). 120–129. 227 indexed citations

13.

Lalaoui, Najoua, Aymeric Morlé, Delphine Mérino, et al.. (2011). TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT. PLoS ONE. 6(5). e19679–e19679. 55 indexed citations

14.

Morizot, Alexandre, Delphine Mérino, Najoua Lalaoui, et al.. (2010). Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level. Cell Death and Differentiation. 18(4). 700–711. 65 indexed citations

15.

Mérino, Delphine, Maybelline Giam, Peter Hughes, et al.. (2009). The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteins. The Journal of Cell Biology. 186(3). 355–362. 149 indexed citations

16.

Mérino, Delphine, Najoua Lalaoui, Alexandre Morizot, Éric Solary, & Olivier Micheau. (2007). TRAIL in cancer therapy: present and future challenges. Expert Opinion on Therapeutic Targets. 11(10). 1299–1314. 138 indexed citations

17.

Larmonier, Nicolas, Dominique Cathelin, Claire B. Larmonier, et al.. (2007). The inhibition of TNF-α anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Experimental Cell Research. 313(11). 2345–2355. 32 indexed citations

18.

Larmonier, Nicolas, Delphine Mérino, Dominique Cathelin, et al.. (2006). Apoptotic, necrotic, or fused tumor cells: An equivalent source of antigen for dendritic cell loading. APOPTOSIS. 11(9). 1513–1524. 33 indexed citations

19.

Lemarié, Anthony, Claudie Morzadec, Delphine Mérino, et al.. (2005). Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-κB-Related Survival Pathway Down-Regulation. Journal of Pharmacology and Experimental Therapeutics. 316(1). 304–314. 68 indexed citations

20.

Mérino, Delphine, Hélène Réglier‐Poupet, Patrick Berche, & Alain Charbit. (2002). A hypermutator phenotype attenuates the virulence of Listeria monocytogenes in a mouse model. Molecular Microbiology. 44(3). 877–887. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact